Position in MDXG
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,682,965
-$2,698,941 QoQ
Shares Held
1,185,561
+8.7% QoQ
Ownership
0.796%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 99.88469593719766.ToString("F0")%
Shared 0.ToString("F0")%
None 0.11530406280233577.ToString("F0")%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. MDXG ranks #182 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,417,875 | $1,079,677,898 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,300,558 | $1,004,863,129 | |
| 3 | MRNA |
Moderna, Inc.
|
6,603,697 | $335,467,805 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
11,111,591 | $307,791,069 | |
| 5 | PRAX |
Praxis Precision Medicines, Inc.
|
710,734 | $228,991,385 | |
| 6 | INCY |
Incyte Corp
|
2,351,221 | $221,296,919 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
2,185,500 | $212,539,874 | |
| 8 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
1,965,432 | $170,933,620 |
All Filings in MDXG
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,682,965 | 1,185,561 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $7,381,906 | 1,090,385 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $8,704,304 | 1,247,035 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,683,675 | 766,559 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $8,525,785 | 1,121,814 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $8,796,691 | 914,417 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $3,883,513 | 657,109 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,847,604 | 699,510 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $4,811,629 | 624,887 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $4,255,527 | 485,237 | Shares | Defined | 2024-05-14 | |
| 2023-09-30 | $3,008,881 | 412,741 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $3,129,708 | 473,481 | Shares | Defined | 2024-05-14 | |
| 2023-03-31 | $1,111,427 | 325,932 | Shares | Defined | 2024-05-14 | |
| 2022-12-31 | $900,917 | 324,071 | Shares | Defined | 2024-05-14 | |
| 2022-09-30 | $833,094 | 290,277 | Shares | Defined | 2024-05-14 | |
| 2022-06-30 | $825,852 | 237,998 | Shares | Defined | 2024-05-14 | |
| 2022-03-31 | $996,070 | 211,480 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $907,973 | 150,327 | Shares | Defined | 2022-02-17 | |
| 2021-09-30 | $456,286 | 75,295 | Shares | Defined | 2022-01-20 | |
| 2021-06-30 | $487,251 | 38,949 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $2,910,007 | 282,525 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $185,767 | 20,459 | Shares | Defined | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||